Phase II trial of single agent amrubicin (A) in patients (pts) with previously treated advanced thymic malignancies (TM).

被引:0
|
作者
Wakelee, Heather A.
Padda, Sukhmani Kaur
Burns, Matthew
Spittler, Aaron John
Riess, Jonathan
San Pedro-Salcedo, Melanie
Ramchandran, Kavitha
Gubens, Matthew A.
Neal, Joel W.
Loehrer, Patrick J.
机构
[1] Stanford Univ, Sch Med, Stanford Canc Inst, Stanford, CA 94305 USA
[2] Indiana Univ, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46204 USA
[3] Univ Calif Davis, Ctr Comprehens Canc, Sacramento, CA 95817 USA
[4] UC San Francisco, San Francisco, CA USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
7580
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Phase I trial of SNS-595 in patients (pts) with advanced malignancies.
    Advani, R
    Gordon, M
    Hurwitz, H
    Mendelson, D
    Wakelee, H
    Ebbinghaus, S
    Hoch, U
    Silverman, J
    Havrilla, N
    Adelman, D
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9056S - 9056S
  • [32] A Phase II trial of topotecan and gemcitabine in patients with previously treated, advanced nonsmall cell lung carcinoma
    Rinaldi, DA
    Lormand, NA
    Brierre, JE
    Cole, JL
    Barnes, BC
    Mills, G
    Yadlapati, S
    Fontenot, MF
    Buller, EJ
    Rainey, JM
    CANCER, 2002, 95 (06) : 1274 - 1278
  • [33] Phase I trial of SU014813 in patients (pts) with advanced solid malignancies
    Fiedler, W. M.
    Giaccone, G.
    Lasch, P.
    Van der Horst, I.
    Brega, N. M.
    Raber, S.
    Shalinsky, D.
    Ljubmir, V.
    Bokemeyer, C.
    Boven, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [34] Phase II trial of 96-hour paclitaxel in previously treated patients with advanced esophageal cancer
    Anderson, SE
    O'Reilly, EM
    Kelsen, DP
    Ilson, DH
    CANCER INVESTIGATION, 2003, 21 (04) : 512 - 516
  • [35] Phase II trial of single agent bortezomib (VELCADE®) in patients with previously untreated multiple myeloma (MM)
    Richardson, PG
    Chanan-Khan, A
    Schlossman, RL
    Munshi, NC
    Wen, P
    Briemberg, H
    Kuter, D
    Oaklander, AL
    Lonial, S
    Hassoun, H
    Doss, D
    Colson, K
    McKenney, M
    Hande, K
    Koryzna, A
    Stoklas, B
    Lunde, L
    Gorelik, S
    McAlister, C
    Freeman, A
    Warren, D
    Collins, D
    Esseltine, D
    Amato, A
    Anderson, KC
    BLOOD, 2004, 104 (11) : 100A - 100A
  • [36] Prospective Feasibility Study of Amrubicin and Bevacizumab Therapy for Patients With Previously Treated Advanced NSCLC
    Imai, Hisao
    Kaira, Kyoichi
    Naruse, Ichiro
    Kasahara, Norimitsu
    Kamide, Yosuke
    Ono, Akihiro
    Masuda, Tomomi
    Sunaga, Noriaki
    Minato, Koichi
    Hisada, Takeshi
    ANTICANCER RESEARCH, 2020, 40 (03) : 1571 - 1578
  • [37] FIGHT-202: A phase II study of pemigatinib in patients (pts) with previously treated locally advanced or metastatic cholangiocarcinoma (CCA)
    Vogel, A.
    Sahai, V.
    Hollebecque, A.
    Vaccaro, G.
    Melisi, D.
    Al-Rajabi, R.
    Paulson, A. S.
    Borad, M. J.
    Gallinson, D.
    Murphy, A. G.
    Oh, D-Y.
    Dotan, E.
    Catenacci, D. V.
    Van Cutsem, E.
    Lihou, C. F.
    Zhen, H.
    Feliz, L.
    Abou-Alfa, G. K.
    ANNALS OF ONCOLOGY, 2019, 30 : 876 - 876
  • [38] A phase II study of regorafenib in patients with thymic epithelial tumours previously treated with chemotherapy.
    Perrino, Matteo
    Bozzarelli, Silvia
    Zucali, Paolo Andrea
    De Pas, Tommaso Martino
    Simonelli, Matteo
    De Vincenzo, Fabio
    Conforti, Fabio
    Persico, Pasquale
    Miggiano, Chiara
    Cordua, Nadia
    Cioffi, Angela
    Sala, Simona
    Sposta, Federica Mrakic
    Giordano, Laura
    Santoro, Armando
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [39] PHASE-II TRIAL OF CISPLATIN (CPDD) IN PREVIOUSLY TREATED PATIENTS WITH ADVANCED SOFT-TISSUE SARCOMA
    BRENNER, J
    MAGILL, GB
    SORDILLO, PP
    CHENG, EW
    YAGODA, A
    CANCER, 1982, 50 (10) : 2031 - 2033
  • [40] A phase II clinical trial of selinexor in patients with advanced thymoma and thymic carcinoma
    Aggarwal, Vanya
    Tang, Tianzhi
    Daugaard, Gedske
    Liu, Stephen V.
    Ahn, Jaeil
    Besse, Benjamin
    Girard, Nicolas
    Giaccone, Giuseppe
    Kim, Chul
    Petersen, Peter
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)